- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03300713
MOther-Child Interaction Assessment TRAINING for Pediatricians (MOCITRAINING)
September 30, 2022 updated by: University Hospital, Lille
The originality of the MOCITRAINING study lies in the integration of infant and maternal care during the pediatric consultation and the assessment of the impact of this type of care in the short and medium term on The MOCITRAINING program could contribute to improving the quality of parent-child interactions.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
3504
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Renaud Jardri, MD,PhD
- Phone Number: +33 (0) 320 446 747
- Email: renaud.jardri@chru-lille.fr
Study Locations
-
-
-
Lille, France
- Recruiting
- CHU
-
Principal Investigator:
- Renaud Jardri, MD,PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 weeks to 1 month (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Each child will be included WITH his biological mother at the first-month visit after birth.
- Age: 1 month + / - 15 days (child), accompanied by his biological mother
- Mother able to read French;
- Signed consent letter after complete information of parents about the MOCITRAINING study, its principle, advantages and disadvantages.
Exclusion Criteria:
- Preterm babies.
- Children from a twin or multiple pregnancy.
- Children with somatic diagnosis explaining the presence of digestive, sleeping or interactional disorders.
- Refusal to participate after clear information about the study;
- Refusal to sign the consent letter;
- Refusal to be informed of a diagnostic hypothesis;
- Participants not covered by the Social Security system;
- Participants incapable of consenting or under legal protection (guardianship or curatorship).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: F+ group (Mocitraining program)
including 8 pediatricians' clusters.
F+ pediatricians will attend a specific training focused on mother-child interactions, maternal psychiatric disorders, particularly PND screening and early interventions for non-psychiatric physician.
|
The program is clinical and psychometric tools for screening for interactions and postpartum psychiatric disorders.
The program will expose the existing care arrangements and the different possible orientations of the families according to the identified problem.
|
Sham Comparator: F- group (usual follow-up)
grouping 8 pediatricians' clusters.
They will not receive the initial training on early interactional disorders and PND screening
|
usual follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Frequency of pathological Alarm Distress BaBy (ADBB) scores
Time Frame: in 12-month-aged children.
|
in 12-month-aged children.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of pathological Alarm Distress BaBy (ADBB) scores
Time Frame: in 4, 9 and 24 month-aged children
|
in 4, 9 and 24 month-aged children
|
|
Frequency of digestive disorders
Time Frame: in 4, 9, 12 and 24 month-aged children
|
presence/absence of infantile regurgitations and colics
|
in 4, 9, 12 and 24 month-aged children
|
Number of daytime sleep hours
Time Frame: in 4, 9, 12 and 24 month-aged children
|
in 4, 9, 12 and 24 month-aged children
|
|
Number of nighttime awakenings
Time Frame: in 4, 9, 12 and 24 month-aged children
|
in 4, 9, 12 and 24 month-aged children
|
|
Scores on maternal self-evaluation scales (Likert scales)
Time Frame: at 12 and 24 months postpartum
|
Scores on maternal self-evaluation scales (Likert scales) about parent-child relations (Items concerning comfort and pleasure during interactions)
|
at 12 and 24 months postpartum
|
Frequency of dyads referred for psychiatric or perinatal psychiatric consultations
Time Frame: in 4, 9, 12 and 24 month-aged children
|
in 4, 9, 12 and 24 month-aged children
|
|
Frequency of maternal psychotropic medication
Time Frame: in 4, 9, 12 and 24 month-aged children
|
in 4, 9, 12 and 24 month-aged children
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Renaud Jardri, MD, PhD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2017
Primary Completion (Anticipated)
December 1, 2026
Study Completion (Anticipated)
December 1, 2026
Study Registration Dates
First Submitted
September 28, 2017
First Submitted That Met QC Criteria
September 28, 2017
First Posted (Actual)
October 3, 2017
Study Record Updates
Last Update Posted (Actual)
October 3, 2022
Last Update Submitted That Met QC Criteria
September 30, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015_04
- 2016-A00540-51 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression, Postpartum
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Women's Health Research Institute...CompletedPostpartum Depression | Perinatal Disorder | Postpartum Disorder | Perinatal Depression | Postpartum Anxiety | Postnatal DepressionCanada
-
University of CoimbraEnrolling by invitationPostPartum DepressionPortugal
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Sage TherapeuticsCompletedSevere Postpartum DepressionUnited States
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalCompletedPostpartum Depression | Postpartum Anxiety | Postpartum Blues | Postpartum Mood DisorderCanada
-
Gazi UniversityCompletedPostpartum Depression | Postpartum AdaptationTurkey
-
British Columbia Children's HospitalActive, not recruiting
-
University of RochesterMae Stone Goode FoundationCompletedPostpartum Depression | Postpartum AnxietyUnited States
-
Hacettepe UniversityCompletedQuality of Life | Postpartum Depression | Nursing Caries | Nurse's Role | Postpartum Disorder | Postpartum AnxietyTurkey
Clinical Trials on MOCITRAINING program
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
National Taiwan University HospitalCompleted
-
University of Maryland, BaltimoreNational Institute of Nursing Research (NINR)CompletedOsteoporosis | Health Behaviors
-
University of AlcalaRecruitingLateral EpicondylitisSpain
-
Massachusetts General HospitalRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
University of CagliariSuspended
-
University of Kansas Medical CenterUnknownUpper Extremity Injuries | Elbow Injuries | Sprain Ulnar Collateral Ligament | Strain of Ulnar Collateral Ligament | Complete Tear Ulnar Collateral LigamentUnited States
-
Sunnybrook Health Sciences CentreToronto Rehabilitation InstituteCompleted
-
Massachusetts General HospitalCompleted
-
Azienda Sanitaria Locale CN1 CuneoNot yet recruiting